NASH and NAFLD, An Issue of Clinics in Liver Disease (Volume 22-1) (The Clinics: Internal Medicine, Volume 22-1)

NASH and NAFLD, An Issue of Clinics in Liver Disease (Volume 22-1) (The Clinics: Internal Medicine, Volume 22-1)

11 $

Format : Publisher PDF

File Size : 7.7 MB

Category:

NASH and NAFLD, An Issue of Clinics in Liver Disease (Volume 22-1) (The Clinics: Internal Medicine, Volume 22-1)

By David Bernstein MD FAASLD FACG FACP AGAF
Obesity has devastating effects on a patient’s overall health, with specific negative effects on organ systems, long-term. The hepatologist must often manage diseases of the liver and pancreas as a result of obesity. This issue will provide a current update on the diagnosis, treatment, and management of NAFLD and NASH. Dr. Bernstein has assembled the top leaders in the field to provide timely clinical reviews. Articles are devoted to the following topics: Clinical and economic burden of NAFLD/NASH; NAFLD/NASH in children and its implications; Natural history of NAFLD/NASH; Diagnosis and evaluation of NAFLD/NASH; Radiological imaging in NAFLD/NASH; The use of liver biopsy in NAFLD: When to biopsy and in whom; Pathophysiology of NAFLD/NASH; Risk factors for the development of NAFLD/NASH including genetics; Role of intestinal microbes in NAFLD/NASH; NAFLD/NASH and the metabolic syndrome; NAFLD/NASH and lipid and insulin resistance; NAFLD/NASH and cardiac disease; Current treatment of NAFLD/NASH; Emerging treatment of NAFLD/NASH; NAFLD/NASH and HCC and NAFLD/NASH and liver transplantation. Readers will have a clear understanding of how to manage outcomes for these patients.

Book Review: Obesity and the Liver: Diagnosis and Management of NAFLD and NASH

Obesity is a growing epidemic that affects millions of individuals worldwide. It not only affects a person’s physical appearance, but it also has devastating effects on their overall health. One of the organ systems that are most affected by obesity is the liver. Obesity can lead to the development of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These conditions can have serious long-term implications and require proper diagnosis and management.

Overview

Understanding the diagnosis and management of NAFLD and NASH is crucial for healthcare professionals who deal with patients suffering from obesity-related liver diseases. In the book “Obesity and the Liver: Diagnosis and Management of NAFLD and NASH,” Dr. David Bernstein has brought together the top leaders in the field to provide a comprehensive and up-to-date review of the topic.

The book covers a wide range of topics related to NAFLD and NASH, starting with the clinical and economic burden of these conditions. It goes on to discuss the implications of NAFLD and NASH in children, the natural history of the diseases, and the diagnosis and evaluation of patients. Various imaging techniques used in the diagnosis of NAFLD and NASH are reviewed in detail.

A significant portion of the book is dedicated to the use of liver biopsy in NAFLD, including the indications and the patient population in which it should be performed. The pathophysiology of NAFLD and NASH is explored, along with the role of intestinal microbes and genetics in the development of these diseases. The relationship between NAFLD and NASH with other metabolic conditions, such as the metabolic syndrome, lipid and insulin resistance, and cardiac disease, is also thoroughly discussed.

Treatment options and emerging therapies for NAFLD and NASH are covered in detail, providing readers with insights into the current and future management strategies for these conditions. The book also explores the relationship between NAFLD and NASH with hepatocellular carcinoma (HCC) and liver transplantation.

Why You Should Order This Book

If you are a healthcare professional dealing with patients suffering from obesity-related liver diseases, “Obesity and the Liver: Diagnosis and Management of NAFLD and NASH” is a must-have resource for your library. It provides a comprehensive and up-to-date review of the diagnosis, treatment, and management of these conditions, as well as insights into emerging therapies. This book will provide you with the knowledge and tools needed to effectively manage outcomes for your patients.

The expertise of Dr. David Bernstein and the top leaders in the field ensures that the information presented in the book is of the highest quality and based on the latest research and clinical practices. You can trust that the content is reliable and relevant to your practice.

In addition to its informative content, the book is also well-organized and easy to navigate. Each chapter focuses on a specific aspect of NAFLD and NASH, allowing readers to quickly find the information they need. The inclusion of numerous tables, figures, and illustrations enhances the understanding and clarity of the topics discussed.

The book is published by Elsevier, a reputable publisher known for producing high-quality medical literature. The 1st edition of the book was released on December 19, 2017, ensuring that the content is current and reflects the latest advancements in the field.

Product Details:

  • Publisher: Elsevier; 1st edition (December 19, 2017)
  • Language: English
  • ISBN-10: 0323569862
  • ISBN-13: 978-0323569866

Whether you are a hepatologist, gastroenterologist, or any healthcare professional involved in the management of obesity-related liver diseases, “Obesity and the Liver: Diagnosis and Management of NAFLD and NASH” is a valuable resource that will deepen your understanding of these conditions and help improve patient outcomes. Order your copy today and stay informed on the latest advancements in the field.

(Insert Order Now CTA here)

Product Details

  • Publisher ‏ : ‎ Elsevier; 1st edition (December 19, 2017)
  • Language ‏ : ‎ English
  • ISBN-10 ‏ : ‎ 0323569862
  • ISBN-13 ‏ : ‎ 978-0323569866

Related Products